Primary biliary cholangitis trials in Greece
4 of 4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSeladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Where
- Athens, Larissa, Thessaloniki
- Age
- 18 years and over
- People
- 402 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01 - Phase 3Taking peopleA Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
- Where
- Athens, Kifissia, Thessaloniki
- Age
- 18 years and over
- People
- 276 worldwide
- Run by
- Ipsen
See details and how to joinNCT06016842 · EU 2023-505251-43-00 - Phase 3Taking peopleStudy of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
- Where
- Athens
- Age
- 18 years to 80 years
- People
- 90 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07424677 · EU 2026-526680-38-00 - Phase 3Taking peopleLong-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
- Where
- Athens, Thessaloniki
- Age
- 18 years to 64 years
- People
- 386 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07216235 · EU 2025-524067-20-00